Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VMD · against 400 other Healthcare companies of similar size
Ranked #265 of 401 · scores higher than 34% of peers · safety percentile 39
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)35 peers with a safety percentile of 30–39, including VMD · Click a bar to see the companies
A mix: stronger debt / equity, but weaker current ratio and beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 367 reported | 0.08× | 0.19× | 63% | 33% | |
| BetaLower is better · 385 reported | 1.09 | 0.44 | 19% | 33% | |
| Current ratioHigher is better · 393 reported | 1.13× | 3.03× | 13% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 421M USD | 99 | 52 | |
| 3 | 261M USD | 99 | 97 | |
| 4 | 397M USD | 99 | 37 | |
| 5 | 455M USD | 99 | 53 | |
| 261 | 241M USD | 40 | ||
| 262 | 57.0B INR (≈$684M) | 39 | 40 | |
| 263 | 2.1B CNY (≈$301M) | 39 | 21 | |
| 264 | 672.6B KRW (≈$484M) | 39 | 69 | |
| 265 | 360M USD | 39 | 67 | |
| 266 | 585.5B KRW (≈$422M) | 38 | 63 | |
| 267 | 2.2B CNY (≈$308M) | 38 | 18 | |
| 268 | 3.7B CNY (≈$524M) | 38 | 54 | |
| 269 | 2.9B CNY (≈$411M) | 38 | 23 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score